129 related articles for article (PubMed ID: 31375477)
21. AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.
Gicquel E; Maizonnier N; Foltz SJ; Martin WJ; Bourg N; Svinartchouk F; Charton K; Beedle AM; Richard I
Hum Mol Genet; 2017 May; 26(10):1952-1965. PubMed ID: 28334834
[TBL] [Abstract][Full Text] [Related]
22. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
23. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation.
Riemersma M; Froese DS; van Tol W; Engelke UF; Kopec J; van Scherpenzeel M; Ashikov A; Krojer T; von Delft F; Tessari M; Buczkowska A; Swiezewska E; Jae LT; Brummelkamp TR; Manya H; Endo T; van Bokhoven H; Yue WW; Lefeber DJ
Chem Biol; 2015 Dec; 22(12):1643-52. PubMed ID: 26687144
[TBL] [Abstract][Full Text] [Related]
24. Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes.
Blaeser A; Keramaris E; Chan YM; Sparks S; Cowley D; Xiao X; Lu QL
Hum Genet; 2013 Aug; 132(8):923-34. PubMed ID: 23591631
[TBL] [Abstract][Full Text] [Related]
25. [Limb-Girdle Muscular Dystrophy type R9 linked to the FKRP gene: state of the art and therapeutic perspectives].
Villar Quiles RN; Richard I; Bouchet-Seraphin C; Stojkovic T
Med Sci (Paris); 2020 Dec; 36 Hors série n° 2():28-33. PubMed ID: 33427633
[TBL] [Abstract][Full Text] [Related]
26. Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model.
Wu B; Drains M; Shah SN; Lu PJ; Leroy V; Killilee J; Rawls R; Tucker JD; Blaeser A; Lu QL
PLoS One; 2022; 17(12):e0278482. PubMed ID: 36454905
[TBL] [Abstract][Full Text] [Related]
27. FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.
Wood AJ; Lin CH; Li M; Nishtala K; Alaei S; Rossello F; Sonntag C; Hersey L; Miles LB; Krisp C; Dudczig S; Fulcher AJ; Gibertini S; Conroy PJ; Siegel A; Mora M; Jusuf P; Packer NH; Currie PD
Nat Commun; 2021 May; 12(1):2951. PubMed ID: 34012031
[TBL] [Abstract][Full Text] [Related]
28. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.
Astrea G; Romano A; Angelini C; Antozzi CG; Barresi R; Battini R; Battisti C; Bertini E; Bruno C; Cassandrini D; Fanin M; Fattori F; Fiorillo C; Guerrini R; Maggi L; Mercuri E; Morani F; Mora M; Moro F; Pezzini I; Picillo E; Pinelli M; Politano L; Rubegni A; Sanseverino W; Savarese M; Striano P; Torella A; Trevisan CP; Trovato R; Zaraieva I; Muntoni F; Nigro V; D'Amico A; Santorelli FM;
Orphanet J Rare Dis; 2018 Sep; 13(1):170. PubMed ID: 30257713
[TBL] [Abstract][Full Text] [Related]
29. A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.
Serafini PR; Feyder MJ; Hightower RM; Garcia-Perez D; Vieira NM; Lek A; Gibbs DE; Moukha-Chafiq O; Augelli-Szafran CE; Kawahara G; Widrick JJ; Kunkel LM; Alexander MS
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232282
[TBL] [Abstract][Full Text] [Related]
30. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
[TBL] [Abstract][Full Text] [Related]
31. Novel FKRP mutations in a Japanese MDC1C sibship clinically diagnosed with Fukuyama congenital muscular dystrophy.
Yoshioka M; Kobayashi K; Toda T
Brain Dev; 2017 Nov; 39(10):869-872. PubMed ID: 28629604
[TBL] [Abstract][Full Text] [Related]
32. Bifunctional catalysis by CDP-ribitol synthase: convergent recruitment of reductase and cytidylyltransferase activities in Haemophilus influenzae and Staphylococcus aureus.
Pereira MP; Brown ED
Biochemistry; 2004 Sep; 43(37):11802-12. PubMed ID: 15362865
[TBL] [Abstract][Full Text] [Related]
33. Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.
Yagi H; Kuo CW; Obayashi T; Ninagawa S; Khoo KH; Kato K
Mol Cell Proteomics; 2016 Nov; 15(11):3424-3434. PubMed ID: 27601598
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C.
Brockington M; Yuva Y; Prandini P; Brown SC; Torelli S; Benson MA; Herrmann R; Anderson LV; Bashir R; Burgunder JM; Fallet S; Romero N; Fardeau M; Straub V; Storey G; Pollitt C; Richard I; Sewry CA; Bushby K; Voit T; Blake DJ; Muntoni F
Hum Mol Genet; 2001 Dec; 10(25):2851-9. PubMed ID: 11741828
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
36. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
[TBL] [Abstract][Full Text] [Related]
37. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
38. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
[TBL] [Abstract][Full Text] [Related]
39. Mobility shift of beta-dystroglycan as a marker of
Sarkozy A; Torelli S; Mein R; Henderson M; Phadke R; Feng L; Sewry C; Ala P; Yau M; Bertoli M; Willis T; Hammans S; Manzur A; Sframeli M; Norwood F; Rakowicz W; Radunovic A; Vaidya SS; Parton M; Walker M; Marino S; Offiah C; Farrugia ME; Mamutse G; Marini-Bettolo C; Wraige E; Beeson D; Lochmüller H; Straub V; Bushby K; Barresi R; Muntoni F
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):762-768. PubMed ID: 29437916
[TBL] [Abstract][Full Text] [Related]
40. Crystallographic analysis of TarI and TarJ, a cytidylyltransferase and reductase pair for CDP-ribitol synthesis in Staphylococcus aureus wall teichoic acid biogenesis.
Li FKK; Gale RT; Petrotchenko EV; Borchers CH; Brown ED; Strynadka NCJ
J Struct Biol; 2021 Jun; 213(2):107733. PubMed ID: 33819634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
